U.S. Life Sciences Stock News

Upcoming Earnings Put Manhattan Associates In Focus Manhattan Associates (MANH) is back on investors’ radar as the supply chain software company heads into its earnings report this Tuesday after the bell, following a prior quarter that topped revenue expectations. See our latest analysis for Manhattan Associates. Manhattan Associates’ recent 10.03% 1 month share price return and 8.09% 3 month share price return contrast with a year to date share price decline of 9.33% and a 1 year total...

The renewed focus on Talen Energy (TLN) centers on its latest quarterly report, which showed higher revenue and net profit, along with a supportive PJM capacity auction outcome that extends contracted revenue visibility for its fleet. See our latest analysis for Talen Energy. Despite the recent PJM auction support and stronger quarterly figures, Talen Energy’s share price has pulled back, with the 30 day share price return down 10.94% and the year to date share price return down 9.28%. At the...

Recent Price Moves and Business Scale Integer Holdings (ITGR) has attracted fresh attention after recent trading, with the stock last closing at $98.62. The company has a market value of around $3.3 billion and reports annual revenue of about $1.86 billion. See our latest analysis for Integer Holdings. Recent trading has added to a run of stronger share price returns for Integer Holdings, with a 30 day share price return of 5.04% and a year to date gain of 28.44% even though the 1 year total...

How TJX Companies Stock Has Been Performing TJX Companies (TJX) has delivered a total return of 24.50% over the past year and 85.44% over the past 3 months, with the stock last closing at US$154.22. Shorter term moves have been more muted, with the stock up 0.48% on the day and down 0.95% over the past week. Over the past month the stock shows a decline of 0.78%, and year to date performance is slightly lower by 0.04%. See our latest analysis for TJX Companies. For TJX Companies, the share...

Triumph Financial (TFIN) has drawn investor attention after reporting second quarter 2026 results, with net interest income of US$98.83 million and net income of US$11.37 million from continuing operations. See our latest analysis for Triumph Financial. Following the earnings release, Triumph Financial's share price has eased in the very short term, with a 1-day share price return down 3.75% and a 7-day share price return down 1.21%. However, the 90-day share price return of 13.69%, year to...

RB Global, Inc. previously announced that on July 21, 2026, its Board of Directors declared a quarterly cash dividend of US$0.33 per common share, payable on September 17, 2026 to shareholders of record on August 25, 2026, and classified as an eligible dividend for Canadian income tax purposes. This dividend decision highlights the company’s ongoing cash returns to shareholders while it continues to operate global marketplaces for commercial assets and vehicles under brands such as Ritchie...

First Industrial Realty Trust (FR) has drawn fresh attention after reporting second quarter 2026 earnings, with sales of US$194.94 million and net income of US$77.1 million, alongside updated half-year results. See our latest analysis for First Industrial Realty Trust. At a share price of US$66.99, First Industrial Realty Trust has posted a 5.36% 30 day share price return and a 15.70% year to date share price return, while the 1 year total shareholder return of 41.89% points to momentum that...

SLM (SLM) shares are in focus after the company reported second quarter 2026 earnings and affirmed a quarterly dividend of $0.13 per share, with payment scheduled for September 15, 2026. See our latest analysis for SLM. At a share price of $24.29, SLM has seen its 7 day and 30 day share price returns decline 4.11% and 4.56% respectively, while the 1 year total shareholder return is down 24.33% but the 3 year total shareholder return is up 60.27%. This suggests longer term holders have fared...

The recent Cyclospora outbreak has pushed food safety, traceability, and testing to the top of investors’ watchlists. When regulators, distributors, and restaurant suppliers come under pressure, attention often shifts to companies that help monitor, test, and verify what moves through the food supply chain. This article looks at how that news may affect a handful of Food Safety & Testing Companies, and why some stocks could be positioned as potential beneficiaries of higher scrutiny and...

Consumer discretionary stocks are back in focus as markets react to falling oil prices, upcoming mega cap tech earnings, and the Federal Reserve’s next rate call. Lower fuel costs can reshape household budgets, while big tech results and policy signals may influence overall risk appetite. In addition, legal delays around the Paramount and Warner Bros. Discovery deal and new questions about AI rules are adding another layer of uncertainty. This article breaks down how these forces tie into...

In July 2026, Phillips Edison & Company reported second-quarter revenue of US$189.62 million and net income of US$41.12 million, alongside higher earnings per share versus a year earlier, and raised its 2026 diluted net income guidance to US$0.95–US$0.97 per share from US$0.79–US$0.81. The combination of higher current-period profits and an upward revision to full-year earnings guidance highlights management’s increased confidence in the company’s operating performance. With this stronger...

Renewed EU regulation and tariff threats are putting global tech stocks under a spotlight, while many US domestic focused technology companies sit slightly to one side of the crossfire. For investors sorting through the noise, the question is which stocks appear more insulated from these trade and regulatory headlines and which still carry meaningful exposure. This article examines how the latest EU actions and US tariff rhetoric could affect sentiment around certain US tech companies, and...

Nektar Therapeutics (NKTR) has launched the first two global Phase 3 ZENITH AD trials for rezpegaldesleukin in moderate to severe atopic dermatitis, supported by earlier Phase 2b data and FDA Fast Track designations. See our latest analysis for Nektar Therapeutics. The latest rezpegaldesleukin Phase 3 launch comes after a sharp shift in sentiment around Nektar Therapeutics, with a 1-year total shareholder return of 199.05% and a year to date share price return of 62.89%. However, momentum has...

Qiagen (QGEN) is back in focus after highlighting its molecular testing tools in the U.S. cyclosporiasis response and launching a CE-IVDR-certified bloodstream infection and antimicrobial resistance panel for its QIAstat-Dx platform in Europe. See our latest analysis for Qiagen. Qiagen’s recent focus on infectious disease diagnostics comes as the stock trades at US$41.37, with a 90 day share price return of 21.6% but a year to date share price return that is down 13.03%, and a 1 year total...

Enterprise Financial Services Corp has reported past second-quarter and six-month 2026 results showing higher net interest income but lower net income and earnings per share compared with a year earlier, alongside a quarterly dividend of US$0.35 per share payable on September 30, 2026. At the same time, the company completed a multi‑year share repurchase totaling 1,750,600 shares, expanded its buyback authorization to 4,000,000 shares, and continued distributing dividends, signaling a clear...

Gaming and Leisure Properties (GLPI) is back on investor radars after a recent move in its share price, with the stock closing at $45.17. That shift has renewed interest in its underlying real estate fundamentals. See our latest analysis for Gaming and Leisure Properties. Over the past year, Gaming and Leisure Properties has paired a 5.77% total shareholder return with relatively muted share price moves. The recent 1-day share price return of 1.69% contrasts with a 90-day share price return...

Commvault Systems (CVLT) is back in focus this week as the data protection software company prepares to report earnings before markets open on Tuesday, with investors watching a projected slowdown in revenue growth. See our latest analysis for Commvault Systems. At a share price of $142.31, Commvault Systems has posted a 45.24% 90 day share price return, yet the 1 year total shareholder return is down 12.92%. This indicates that recent momentum is improving compared with a weaker longer term...

Earlier this year, Unusual Machines, Inc. announced a collaboration with Lantronix Inc. to develop autonomous drone components that combine edge AI computing with flight control systems for the commercial drone market. This partnership could strengthen Unusual Machines’ position in higher-value drone technologies by pairing its hardware capabilities with Lantronix’s embedded computing and connectivity expertise. We’ll now examine how this edge AI and flight-control collaboration with...

HBT Financial (HBT) is back on investors’ radar after reporting second quarter earnings that topped analyst estimates, alongside a higher quarterly dividend and continued share repurchases. See our latest analysis for HBT Financial. That backdrop of better than expected earnings, a higher dividend and ongoing buybacks sits alongside firm recent share price momentum, with a 16.24% 3 month share price return, 29.48% year to date share price return and a 33.98% 1 year total shareholder...

Why Snap-on stock is back in focus after fresh earnings Snap-on (SNA) has moved back onto investor watchlists after reporting second quarter and year-to-date results that showed higher sales, net income, and earnings per share compared with the prior year. See our latest analysis for Snap-on. Alongside the latest earnings, Snap-on’s share price has gained 7.04% over the past 90 days and its 1-year total shareholder return of 27.17% and 5-year total shareholder return of 110.06% point to...

Q2 earnings and buybacks put T-Mobile US (TMUS) under the spotlight T-Mobile US (TMUS) has drawn investor attention after reporting second quarter 2026 results alongside an update on its ongoing share repurchase program, combining fresh earnings data with a clearer view of capital returns. For the quarter ended June 30, 2026, the company reported revenue of US$22,791 million compared with US$21,132 million a year earlier, while net income was US$3,239 million versus US$3,222 million in the...

FTI Consulting (FCN) has drawn attention after appointing Dylan Ryan and Emmanuel Fages as Senior Managing Directors, moves that sharpen its focus on financial crime risk management and energy and utilities advisory work for global clients. See our latest analysis for FTI Consulting. FTI Consulting's latest executive hires arrive as the stock trades at $159.79, with a 1-day share price return of 1.49% and a 30-day share price return of 5.75%. This contrasts with a 1-year total shareholder...

With the Federal Reserve sitting on a knife edge between holding rates and a possible 25 basis point hike, interest rate expectations, bond yields, and renewed Middle East tensions are back in the spotlight for banking and financial stocks. Higher oil prices and mixed inflation signals are feeding fresh volatility into funding costs and loan demand, while two year Treasury yields around 4% keep rate hike odds alive. This article looks at three large, financially healthy stocks from our...

ICON (NasdaqGS:ICLR) has drawn investor attention after recent share performance data highlighted a mix of short term declines and longer term gains, which has prompted a closer look at how the clinical research company is currently valued. See our latest analysis for ICON. At a share price of $165.76, ICON’s recent pattern combines a sharp 90 day share price return of 61.73% with a decline of 12.60% in the 1 year total shareholder return. This suggests strong recent momentum following a...